Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tumor Markers, Liquid Biopsies, and Patient Reported Outcomes in Metastatic Colorectal, Pancreas, Biliary, and Esophagogastric Cancers

NCT04776837 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04776837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04776837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tumor Markers, Liquid Biopsies, and Patient Reported Outcomes in Metastatic Colorectal, Pancreas, Biliary, and Esophagogastric Cancers
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Completed
Start date
May 15, 2019
Completion date
October 19, 2022
Enrollment
159 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract cancer, colorectal cancer, disease progression, esophageal cancer, metastatic cancer, pancreatic cancer, patient reported outcome measures, survival analysis